ArticleHeliyon2024

MiR-424-5p suppresses tumor growth and progression by directly targeting CHEK1 and activating cell cycle pathway in Hepatocellular Carcinoma.

Chunlin Yin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.